The quality partner that can keep up with your ambition.
In 2017 Ivo Schefman and Robin de Bruijn identified the unmet need for ready to use pharmaceutical grade cannabis-based ingredients. Looking at the enormous body of scientific research, ever more progressive cannabis laws, and enthusiastic public opinion, they saw what the true potential of their technology in this emerging cannabis market could be and decided to go for it. Stabican b.v. was officially founded in January 2019 in Almere, The Netherlands.
Stabican was founded with the aim of making cannabis-based pharmaceutical and food products possible that meet the highest standards of the pharmaceutical industry and fit within the current regulatory system.
We offer quality, scalability and speed to help growing this emerging industry and to keep up with our customers ambition.
In 2019 we started our office in Almere, The Netherlands, and hired an experienced team to research and further develop our concept. Since then we’ve developed and protected our technology platform that doesn’t only solve stability and processing problems of cannabinoids, but is also designed for formulating and delivering lipophilic (i.e. fat-soluble) active ingredients including vitamin A, D, E, K, nicotine and psilocin. In 2021 we moved into our own research and manufacturing laboratory in Bergen op Zoom, the Netherlands.
While developing Active Pharmaceutical Ingredients (APIs), we identified the lack of experienced and EU-GMP certified product testing laboratories. This was not only key for our own developments but for all companies working in this industry. And again, we hired the right experienced people with over 20 years of experience in this field, bought the right analytical equipment and now also offer product testing services in our laboratory which will be EU-GMP certified in July 2022.
Jan de Vries
Jan de Vries was co-owner of 'Sinensis Life Sciences' and has over 20 years of experience in the field of medical cannabis products, extraction, quality control, manufacturing and GMP. He leads all operations, determines how product claims should be demonstrated, shares market insights and his network.
Robin de Bruijn
CTO / Co - founder
Robin is an expert in drug delivery systems and was CEO and co-founder of Emultech. In this role, he has built a successful company that develops and sells drug delivery equipment to the
pharmaceutical industry. With a cum laude master's degree in Process Engineering (TU Eindhoven), he brings a lot of technical and analytical knowledge to the team. He also has a diploma for Master of Business Innovation.